Recombinant multi-species eEF2K/EEF2K/eEF-2K protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine eEF2K/EEF2K/eEF-2K protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CaMKIII,Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase,EEF2K,Eef2k,Eukaryotic elongation factor 2 kinase,HSU93850,SMEF2K,eEF-2 kinase,eEF-2K,eEF2K

Target products collectionGo to eEF2K/EEF2K/eEF-2K products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T92494-Ag-1/ GM-Tg-hg-T92494-Ag-2 Human eEF2K/EEF2K/eEF-2K protein Human
GM-Tg-rg-T92494-Ag-1/ GM-Tg-rg-T92494-Ag-2 Rat eEF2K/EEF2K/eEF-2K protein Rat
GM-Tg-mg-T92494-Ag-1/ GM-Tg-mg-T92494-Ag-2 Mouse eEF2K/EEF2K/eEF-2K protein Mouse
GM-Tg-cynog-T92494-Ag-1/ GM-Tg-cynog-T92494-Ag-2 Cynomolgus/Rhesus macaque eEF2K/EEF2K/eEF-2K protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T92494-Ag-1/ GM-Tg-felg-T92494-Ag-2 Feline eEF2K/EEF2K/eEF-2K protein Feline
GM-Tg-cang-T92494-Ag-1/ GM-Tg-cang-T92494-Ag-2 Canine eEF2K/EEF2K/eEF-2K protein Canine
GM-Tg-bovg-T92494-Ag-1/ GM-Tg-bovg-T92494-Ag-2 Bovine eEF2K/EEF2K/eEF-2K protein Bovine
GM-Tg-equg-T92494-Ag-1/ GM-Tg-equg-T92494-Ag-2 Equine eEF2K/EEF2K/eEF-2K protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T92494-Ag-1/ GM-Tg-hg-T92494-Ag-2; GM-Tg-rg-T92494-Ag-1/ GM-Tg-rg-T92494-Ag-2;
GM-Tg-mg-T92494-Ag-1/ GM-Tg-mg-T92494-Ag-2; GM-Tg-cynog-T92494-Ag-1/ GM-Tg-cynog-T92494-Ag-2;
GM-Tg-felg-T92494-Ag-1/ GM-Tg-felg-T92494-Ag-2; GM-Tg-cang-T92494-Ag-1/ GM-Tg-cang-T92494-Ag-2;
GM-Tg-bovg-T92494-Ag-1/ GM-Tg-bovg-T92494-Ag-2; GM-Tg-equg-T92494-Ag-1/ GM-Tg-equg-T92494-Ag-2
Products Name eEF2K/EEF2K/eEF-2K protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name eEF2K/EEF2K/eEF-2K
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine eEF2K/EEF2K/eEF-2K protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.